<DOC>
	<DOCNO>NCT01421823</DOCNO>
	<brief_summary>The purpose study assess effect safety alpha agonist ointment fecal incontinence severity patient idiopathic fecal incontinence .</brief_summary>
	<brief_title>A Double Blinded Study Examine Effect Alpha Agonist Ointment Fecal Incontinence Patients With Idiopathic Fecal Incontinence</brief_title>
	<detailed_description>This double blind cross study . Approximately 40 subject participate 4 week study . A screening visit use determine eligibility study . Patients find eligible receive alpha agonist ointment placebo ointment 2 week . This follow second 2 week treatment cycle : - patient previously treat alpha agonist treat placebo . - patient previously treat placebo treat alpha agonist .</detailed_description>
	<mesh_term>Fecal Incontinence</mesh_term>
	<criteria>Signed write informed consent . Male female subject 18 65 year age . Fecal incontinence score 8 . The patient able understand treatment willing comply prescribe regimen . Has clinically significant history presence follow condition : Known allergy API . Porphyria . Glaucoma . Pregnancy lactation . Active past history cardiovascular cerebrovascular disease include unstable angina , myocardial infarction , transient ischemic attacks/stroke , clinically significant arrhythmia , congestive heart failure , cardiac valve abnormality ; Type 1 diabetes mellitus ; Insulin treat type 2 diabetes mellitus . Renal insufficiency . Liver insufficiency . Malignant disease within 5 year screen ; Has hypertension ( sit blood pressure 140/90 mmHg screen ) History rectal surgery . History HIV , hepatitis B , hepatitis . Has use , last four week , drug may affect blood coagulation , Aspirin ( dose 250 mg/day ) , Warfarin , Sintrom , Enoxaparin , Nadroparin , Heparin , Clopidogrel , Ticlopidine . Use tricyclic monoamineoxidase inhibitor . Has upon physical examination rectal deformation sign rectal disease fissure , bleed hemorrhoid , fistula. , infection space occupy lesion . Unable understand use instruction ointment , judge investigator .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>Fecal Incontinence</keyword>
	<keyword>Alpha agonist</keyword>
</DOC>